Diagnosis Biotech
Diagnosis Biotech was founded in 2020 in response to the COVID-19 pandemic to find ways to enable mass testing for broad SARS-CoV-2 screening. We developed and validated Phone Screen Testing (PoST), a new accurate, low-cost and non-invasive method to test SARS-CoV-2 from the screen of smartphones. PoST was shown to be as accurate in identifying COVID-19 contagious people as nasopharyngeal sampling. We are now working on expanding the B2B and B2C COVID-19 testing service from Chile, where PoST was piloted, to LATAM, the UK and USA. In parallel, we are developing the first PoST machine that will take and analyse samples from phones to identify over 50 pathogens in 10 minutes. The aim is to generate a broad and distributed network of PoST machines to enable mass testing for epidemiological surveillance of all kinds of infectious diseases.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
3
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
1
organic / mo
Sign up free to see all 2 verified contacts at Diagnosis Biotech
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Diagnosis Biotech
2 distinct titles indexed · top 2 shown.
- 1ingeniero en biotecnología
- 1social media designer
Sign up to unlock all 2 contacts at Diagnosis Biotech
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Diagnosis Biotech
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.